Finance

GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'

Feb 18, 2025 - 08:45
 0
GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
Read More

Tags:

Previous Article

Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon

Next Article

Maybe Time To Consider International Equities

Related Posts

The U.S. Dollar: An Untapped Portfolio Diversifier

The U.S. Dollar: An Untapped Portfolio Diversifier

Feb 21, 2025  0

Credo Technology: I'd Be Greedy Before The Earnings Rel...

Mar 2, 2025  0

NeoGenomics, Inc. 2024 Q4 - Results - Earnings Call Pre...

Feb 18, 2025  0